Veriheal

JUNE 21, 2023

There will also be measures put in place to control therapeutic access to psilocybin while awaiting federal reform. If approved by the Food and Drug Administration (FDA), this psychedelic would be used to treat chronic and life-threatening mental disorders, especially for patients with limited access to effective treatments.

Access 97

Access Legalization Research and Development Legislation 97

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. billion) by 2025. The post RYAH Group Ships Devices for Use in Pilot Program with Medicann in Jersey, Channel Islands appeared first on CannabisFN.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 5, 2021

Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments, the company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. About Aphrodite Health. About The Conscious Fund.

Research and Development 90

Research and Development Medicine Treatment Programs 90

Cannabis Law Report

MAY 13, 2022

Setting Allocation 3 funding for youth education/intervention/ treatment, environmental restoration, and state and local law enforcement programs at a baseline of $670 million annually for three years. million to help expand access to legal retail throughout California.

Supply Chain 52

Supply Chain Collective Retail Programs 52

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

JUNE 4, 2021

Founded by women, and focused on addressing women’s mental and physical health with psychedelic enhanced treatments. The company has developed a two pronged approach, with a long term drug discovery program to bring an FDA approved drug to market. About Aphrodite Health. About The Conscious Fund.

Research and Development 90

Research and Development Medicine Treatment Programs 90

Cannabis Law Report

SEPTEMBER 27, 2021

“New York continues to represent a tremendous market opportunity, and with the signing into law authorizing the establishment of an adult-use cannabis program and the expansion of the existing medical-use cannabis program, we believe this is an opportune time for Goodness Growth to execute on this highly strategic expansion.

Programs 52

Programs Patients Cultivation Dispensary 52